• Skip to primary navigation
  • Skip to content
  • Skip to footer
  • Estudantes
    • Webmail
    • Moodle
    • Ensino à Distância
    • NetP@
    • Biblioteca
    • Escola Doutoral
    • Serviços Académicos
    • Trabalhar no IHMT
  • Staff
    • Webmail
    • Área de Docentes
    • Área de Não-Docentes

IHMT

Instituto de Higiene e Medicina Tropical

PortuguêsEnglishFrançaisDeutschEspañol

Universidade Nova de Lisboa

  • Ensino
    • Doutoramentos
    • Mestrados
    • Ensino à Distância
    • Cursos de Especialização
    • Cursos de Curta Duração
    • Apoio ao Desenvolvimento
  • Investigação
    • GHTM
  • Doenças Tropicais
    • Glossário
    • Consulta do Viajante
    • Museu
      • Peça do Mês
    • Vídeos
    • MosquitoWeb
  • Unidades de Ensino e de Investigação
  • 5º Congresso Nacional de Medicina Tropical
Home / Archives for Taveira N

Taveira N

Escape from neutralization is a frequent event in HIV-2 infection and is strongly associated with X4 tropism

  • Autores: Antunes F, Barroso H, Borrego P, Doroana M, Marcelino JM, Nilsson C, Novo C, Taveira N
  • Ano de Publicação: 2010
  • Journal: AIDS Research and Human Retroviruses
  • Link: https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=W1nslz6EeRqf8Bzyzm3&page=1&doc=1

Ler mais

Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy

  • Autores: Barroso H, Borrego P, Marcelino JM, Novo C, Quintas A, Rocha C, Taveira N
  • Ano de Publicação: 2010
  • Journal: Journal of Virology
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Potent+and+broadly+reactive+HIV-2+neutralizing+antibodies+elicited+by+a+vaccinia+vector-prime

Human immunodeficiency virus type 2 (HIV-2) infection affects about 1 to 2 million individuals, the majority living in West Africa, Europe, and India. As for HIV-1, new strategies for the prevention of HIV-2 infection are needed. Our aim was to produce new vaccine immunogens that elicit the production of broadly reactive HIV-2 neutralizing antibodies (NAbs). […]
Ler mais

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

  • Autores: Camacho RJ, de Sousa JD, Erasmus S, Faria NR, Goncalves MF, Goubau P, Hodges-Mameletzis I, Jallow S, Lemey P, Paolucci S, Pieniazek D, Rodés B, Ruelle J, Silva JC, Soriano V, Suchard MA, Taveira N, Treviño A, Vandamme AM, Xu L
  • Ano de Publicação: 2012
  • Journal: Journal of General Virology
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Phylogeographical+footprint+of+colonial+history+in+the+global+dispersal+of+human+immunodeficiency+virus+type+2+group+A

Human immunodeficiency virus type 2 (HIV-2) emerged in West Africa and has spread further to countries that share socio-historical ties with this region. However, viral origins and dispersal patterns at a global scale remain poorly understood. Here, we adopt a Bayesian phylogeographic approach to investigate the spatial dynamics of HIV-2 group A (HIV-2A) using a collection of 320 partial pol and 248 partial env sequences sampled throughout 19 countries worldwide.
Ler mais

Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

  • Autores: Barroso H, Bártolo I, Borrego P, Calado R, Cavaco-Silva P, Família C, Gomes P, Leitner T, Marcelino JM, Quintas A, Rocha C, Rosado L, Skar H, Taveira N
  • Ano de Publicação: 2013
  • Journal: Retrovirology
  • Link: http://www.retrovirology.com/content/10/1/110

Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4+ T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are thought to play a central role in HIV-2 evolution and pathogenesis. However, the dynamic of the Nab response and resulting HIV-2 escape during acute infection and their impact in HIV-2 evolution and disease progression remain largely unknown. Our objective was to characterize the Nab response and the molecular and phenotypic evolution of HIV-2 in association with Nab escape in the first years of infection in two children infected at birth.
Ler mais

Origin and Epidemiological History of HIV-1 CRF14_BG

  • Autores: Abecasis AB, Barroso H, Bártolo I, Borrego P, Camacho R, Gomes P, McCutchan F, Taveira N
  • Ano de Publicação: 2011
  • Journal: PLoS One
  • Link: https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=26&SID=P2WA5hwy5j35Sqjoq2z&page=1&doc=1

Background: CRF14_BG isolates, originally found in Spain, are characterized by CXCR4 tropism and rapid disease progression. This study aimed to identify the origin of CRF14_BG and reconstruct its epidemiological history based on new isolates from Portugal.
Ler mais

  • Autores: Barroso H, Bártolo I, Borrego P, Família C, Marcelino JM, Quintas A, Taveira N
  • Ano de Publicação: 2011
  • Journal: PLoS One
  • Link: https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=23&SID=P2WA5hwy5j35Sqjoq2z&page=1&doc=1

Background: Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutralizing antibodies, control viral replication and survive as elite controllers.
Ler mais

https://www.ihmt.unl.pt/publications/3452/

An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity

  • Autores: Barroso H, Borrego P, Calado R, Marcelino JM, Pereira P, Quintas A, Taveira N
  • Ano de Publicação: 2013
  • Journal: Aids
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/23324659

To produce new fusion inhibitor peptides for HIV-1 and HIV-2 based on ancestral envelope sequences.
Ler mais

Baseline susceptibility of primary HIV-2 to entry inhibitors.

  • Autores: Antunes F, Barroso H, Bártolo I, Borrego P, Caixas U, Calado R, Cavaco-Silva P, Doroana M, Maltez F, Marcelino JM, Rocha C, Taveira N
  • Ano de Publicação: 2012
  • Journal: Antiviral Therapy
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Baseline+susceptibility+of+primary+HIV-2+to+entry+inhibitors

BACKGROUND:
The baseline susceptibility of primary HIV-2 to maraviroc (MVC) and other entry inhibitors is currently unknown.
Ler mais

Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia.

  • Autores: Baptista AP, Cavaleiro R, Fernandes S, Foxall RB, Gomes P, Marcelino JM, Soares RS, Sousa AE., Taveira N, Tendeiro R, Victorino RM
  • Ano de Publicação: 2012
  • Journal: Aids
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Memory+B-cell+depletion+is+a+feature+of+HIV-2+infection+even+in+the+absence+of+detectable+viremia

OBJECTIVE:
Memory B-cell loss has long been recognized as an important contributor to HIV immunodeficiency. HIV-2 infection, which is characterized by a slow rate of progression to AIDS and reduced to undetectable viremia, provides a unique model to investigate B-cell disturbances.
Ler mais

Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.

  • Autores: Antunes F, Barroso H, Borrego P, Doroana M, Família C, Maltez F, Marcelino JM, Nilsson C, Quintas A, Taveira N
  • Ano de Publicação: 2012
  • Journal: Aids
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Resistance+to+antibody+neutralization+in+HIV-2+infection+occurs+in+late+stage+disease+and+is+associated+with+X4+tropism

OBJECTIVES:
To characterize the nature and dynamics of the neutralizing antibody (NAb) response and escape in chronically HIV-2 infected patients.
Ler mais

Footer

  • Sobre o IHMT
  • Organização
  • Docentes e Investigadores
  • Serviços Académicos
  • Recursos Humanos
  • Trabalhar no IHMT
  • Instrumentos de Gestão
  • Associação de Alunos e Amigos
  • Parcerias
  • Biblioteca
  • Biobanco GHTM-IHMT – Biotropical Resources
  • Ensino
  • Investigação
  • Cooperação e Desenvolvimento
  • Qualidade

Contactos

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

Contactos dos Serviços

Marcação de consultas:
+351 213 652 630/90
+351 213 627 553
medicina.viagens@ihmt.unl.pt

Subscrever newsletter

Follow us

  • Facebook
  • LinkedIn
  • YouTube
© Copyright 2021 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok